Priscila M.D. Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Priscila M.D. Costa has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bruna dos Santos Machado
Universidade Federal do Rio Grande do Sul, Brazil
1 shared publication - Janyni Duz
Universidade Federal do Rio Grande do Sul, Brazil
1 shared publication - Letícia Machado
Universidade Federal do Rio Grande do Sul, Brazil
1 shared publication - Lívia Eichenberg Surita
Universidade Federal do Rio Grande do Sul, Brasil
1 shared publication - Marcelo Meller Alievi
Universidade Federal do Rio Grande do Sul, Brasil
1 shared publication - Stella Faria Valle
Universidade Federal do Rio Grande do Sul
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Pesquisa Veterinária Brasileira
- Vol. 44, e07359
Oral metformin for type-2 diabetes mellitus treatment in a black-tufted marmoset (Callithrix penicillata)
Type-2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and combined peripheral resistance to the hormone. Several non-human primates (NHP) species develop T2DM, mainly captive animals with reduced physical activity and incorrect feeding. This case report describes the T2DM treatment of a black-eared marmoset (Callithrix penicillata) by diet reformulation and metformin oral administration. An adult female was diagnosed with T2DM after hyperglycemia and high serum fructosamine associated with glycosuria and obesity. Metformin hydrochloride (125mg/animal, orally, q24h) associated with feeding intervention was started. After 26 days, a significant reduction in weight, glycemia, and serum fructosamine could be observed, showing satisfactory results for the adopted therapy. Metformin is considered a safe drug for T2DM treatment due to its low hypoglycemia risk. The new diet consisted of sweet potato, squash, and varied fruits offered twice daily. In addition, thawed-mice newborns, egg whites, and small portions of pelleted primate food. In the present report, metformin use, associated with a low glycemic index diet, was effective in treating this particular marmoset and may present a potential for T2DM treatment in other NHPs.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Pesquisa Veterinária Brasileira
- Vol. 44, e07359
Open AccessOral metformin for type-2 diabetes mellitus treatment in a black-tufted marmoset (Callithrix penicillata)
Type-2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and combined peripheral resistance to the hormone. Several non-human primates (NHP) species develop T2DM, mainly captive animals with reduced physical activity and incorrect feeding. This case report describes the T2DM treatment of a black-eared marmoset (Callithrix penicillata) by diet reformulation and metformin oral administration. An adult female was diagnosed with T2DM after hyperglycemia and high serum fructosamine associated with glycosuria and obesity. Metformin hydrochloride (125mg/animal, orally, q24h) associated with feeding intervention was started. After 26 days, a significant reduction in weight, glycemia, and serum fructosamine could be observed, showing satisfactory results for the adopted therapy. Metformin is considered a safe drug for T2DM treatment due to its low hypoglycemia risk. The new diet consisted of sweet potato, squash, and varied fruits offered twice daily. In addition, thawed-mice newborns, egg whites, and small portions of pelleted primate food. In the present report, metformin use, associated with a low glycemic index diet, was effective in treating this particular marmoset and may present a potential for T2DM treatment in other NHPs.